MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-DL-02-0045153
Medigenesis Pharma Private Limited
Medigenesis Pharma Private Limited - healthcare in Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹1.02 Cr
▲ 20% YoY
Net profit · FY 2024
₹20,009
Net margin 0.2%
EBITDA · FY 2024
₹22,726
EBITDA margin 0.2%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹5.1 Lakh
Issued & subscribed
Company age
10 yrs
Est. 2016
Directors on board
3
As per MCA filings
Active GSTINs
1
GST registered
About Medigenesis Pharma Private Limited
Data last updated:
Medigenesis Pharma Private Limited is a private limited company based in Delhi, India. It operates in the other hospital and medical care activities segment of the healthcare sector. It was incorporated on 15 December 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74999DL2016PTC309240. Its GSTIN is 07AAKCM7124N1Z0 (Delhi).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹5.1 Lakh. It is led by directors including Vishal Maheshwari and Atit Mishra.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Shed No. B – 57 One Office At Second Floor, Work Centre Kalyanpuri, Delhi, India – 110091.
As per the financials filed for FY 2024, the company reported a revenue of ₹1.02 Cr, a growth of 20% compared to the previous year. For the same year it recorded a net profit of ₹20,009 (net margin 0.2%) and EBITDA of ₹22,726 (EBITDA margin 0.2%). Revenue has grown at a compounded annual rate (CAGR) of 20% over three years and 21% over five years.
Medigenesis Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-02-0045153). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U74999DL2016PTC309240
Registration Number 309240
Incorporation Date 15 December 2016
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-DL-02-0045153
Recognitions & Rankings of Medigenesis Pharma
Contact details
Medigenesis Pharma Private Limited's registered office is in Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressShed No. B – 57 One Office At Second Floor, Work Centre Kalyanpuri, Delhi, India – 110091
- IndustryHealthcare, Other Hospital And Medical Care Activities
To see the full contact details of Medigenesis Pharma Private Limited, buy the company report.
Comprehensive company report
Medigenesis Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Medigenesis Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Medigenesis Pharma Private Limited, buy the company report.
Financials of Medigenesis Pharma Private Limited
FY 2025 filings availableMedigenesis Pharma Private Limited reported revenue of ₹1.02 Cr (up 20% YoY) for FY 2024.
Revenue · FY 2024
₹1.02 Cr ▲ 20%
Net profit · FY 2024
₹20,009 margin 0.2%
EBITDA · FY 2024
₹22,726 margin 0.2%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 20%
3 years · compounded
▲ 20%
5 years · compounded
▲ 21%
EBITDA CAGR growth
1 year
▲ 78%
3 years · compounded
▼ 54%
5 years · compounded
▼ 34%
Revenue has grown at a compounded annual rate (CAGR) of 21% over five years, including 20% growth in the latest year. EBITDA rose 78% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹22,726 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹20,009 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.2% | ||||
| Net Profit Margin | 0.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Medigenesis Pharma Private Limited, buy the company report.
Board of directors of Medigenesis Pharma Private Limited
Medigenesis Pharma has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vishal Maheshwari Also directs: Lifejack Pharma Private Limited | Director | 15 Dec 2016 | 9 Years 10 Months | Current |
| Atit Mishra | Director | 04 Apr 2017 | 9 Years 6 Months | Current |
| Banti Singh | Director | 15 Dec 2016 | 9 Years 10 Months | Current |
Peer comparison
Medigenesis Pharma Private Limited is compared with the 5 companies closest to it by revenue in the Healthcare industry (Healthcare Equipment Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Texus Healthcare System Private Limited | ₹1.02 Cr (FY 2025) | 63.0% | Sreekaryam, Kerala, India | |||
| Alam Industries and Export Private Limited | ₹1.02 Cr (FY 2024) | 16.0% | Murshidabad, West Bengal, India | |||
| Chemspirit Instruments & Technologies Private Limited | ₹1.02 Cr (FY 2024) | -8.0% | Selaiyur, Tamil Nadu, India | |||
| Medigenesis Pharma Private Limitedthis company | ₹1.02 Cr (FY 2024) | ₹20,009 | 0.2% | 20.0% | Delhi, India | |
| Pramila Pharmaceuticals Private Limited | ₹1.02 Cr (FY 2025) | -2.0% | Varanasi, Uttar Pradesh, India | |||
| Win Life Medicare Private Limited | ₹1.01 Cr (FY 2024) | -1.0% | Shahdol, Madhya Pradesh, India |
To see the full peer comparison of Medigenesis Pharma Private Limited, buy the company report.
Auditor
Medigenesis Pharma Private Limited is audited by GVAP & Associates for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| GVAP & Associates | FY 2017 | 0788393 |
Shareholding
The shareholding of Medigenesis Pharma Private Limited is on record for FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Medigenesis Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Medigenesis Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Medigenesis Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Medigenesis Pharma has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAKCM7124N1Z0 | Delhi | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Medigenesis Pharma Private Limited, buy the company report.
Recent activity
Medigenesis Pharma Private Limited has 4 board changes on record since 2016: 3 appointments and 1 cessation. The latest: Vikal Kumar ceased to be Director on 06 Feb 2018.
AGM
Medigenesis Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Medigenesis Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi I.
Ceased
Vikal Kumar ceased to be Director.
Appointed
Atit Mishra was appointed as Director.
Appointed
Banti Singh was appointed as Director.
Appointed
Vishal Maheshwari was appointed as Director.
Incorporation
15 Dec 2016
Medigenesis Pharma Private Limited was registered on 15 Dec 2016 with Roc Delhi I & aged 9 years 10 months as per MCA records.
Frequently asked questions
Medigenesis Pharma is an active private limited company based in Delhi, India. The company works in other hospital and medical care activities, within the healthcare industry. It was incorporated on 15 December 2016 (10+ years old) and is registered under CIN U74999DL2016PTC309240.
Medigenesis Pharma has 3 current directors:
- Vishal Maheshwari - Director
- Atit Mishra - Director
- Banti Singh - Director
The latest financial statements of Medigenesis Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Medigenesis Pharma is 07AAKCM7124N1Z0, registered in Delhi.
The CIN (Corporate Identification Number) of Medigenesis Pharma is U74999DL2016PTC309240. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Medigenesis Pharma was incorporated on 15 December 2016, making it 10+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Medigenesis Pharma by revenue are Texus Healthcare System Private Limited, Alam Industries and Export Private Limited, Chemspirit Instruments & Technologies Private Limited, Pramila Pharmaceuticals Private Limited, Win Life Medicare Private Limited, all in the Healthcare industry (Healthcare Equipment Retail and Distribution), with the same principal business activity (wholesale trading).
Vikal Kumar ceased to be Director on 06 Feb 2018. Atit Mishra was appointed as Director on 04 Apr 2017. Banti Singh was appointed as Director on 15 Dec 2016. Medigenesis Pharma has 4 board changes on record in total.
Yes, Medigenesis Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-02-0045153).
The registered office of Medigenesis Pharma is at Shed No. B – 57 One Office At Second Floor, Work Centre Kalyanpuri, Delhi, India – 110091.
Medigenesis Pharma operates in the healthcare industry, in the other hospital and medical care activities segment.